California Hospice Telephone Orders: Staying Compliant When State and Federal Rules Don’t Match
- Oscar Tello
- Jan 29
- 4 min read
Updated: Feb 21
Hospice Care: Navigating Controlled Substance Rules in California
Hospice care is urgent. Controlled substance rules are strict. In California pharmacies, telephone orders for hospice patients are common—but they’re also a high-risk area for audits, diversion concerns, and compliance violations if your workflow isn’t airtight.
Understanding Telephone Orders
A telephone order is a prescription communicated verbally by a prescriber—or an authorized agent—to a pharmacist. In California, oral prescriptions must be reduced to a written, retrievable record as soon as practicable. This ensures that there is a clear and accurate record of the prescription, which is crucial for compliance.
Compliance Risks of Hospice Telephone Orders
Hospice orders are often urgent and frequently involve controlled substances. This combination creates common risk points:
Higher diversion potential
After-hours communication gaps
Incomplete documentation
Confusion about whether hospice status changes controlled substance rules
It's essential to remember that hospice does not eliminate controlled substance requirements—it simply creates specific exceptions when properly used.
State vs. Federal Contradictions: Which Rule Wins?
When state and federal rules conflict, follow the stricter standard. Controlled substance regulation is governed by both California and federal law. Even if California appears to allow a process in certain settings, you should ensure you’re operating inside a federal-compliant pathway before dispensing—especially for Schedule II substances.
California includes provisions allowing certain Schedule II dispensing for patients of licensed hospices and similar facilities with required substantiating documentation. However, federal rules generally require a written or electronic prescription for Schedule II—except in narrowly defined scenarios such as emergency oral Schedule II.
Telephone Orders by Drug Schedule
Non-Controlled Medications
Telephone orders are generally workable if you properly document and reduce the prescription to a record. This means ensuring that all necessary details are captured and stored securely.
Schedule III–V Controlled Substances
California permits dispensing Schedule III–V controlled substances based on oral prescriptions with appropriate records.
Operational guidance: Oral orders can be appropriate—but still require strong verification, corresponding responsibility checks, and complete documentation.
Schedule II Controlled Substances
Schedule II is where confusion and violations often happen. Federal law generally requires a written or electronic prescription—but allows narrow exceptions:
Emergency oral Schedule II (strict conditions + 7-day follow-up requirement).
The Best Compliance Path for Hospice Schedule II
When a hospice patient needs a Schedule II urgently, the most compliant approach is to request an electronic prescription from the prescriber. If the dispensing event qualifies as an emergency fill, the pharmacy should follow established policies and procedures to document, fill, and track submission of physical or electronic prescriptions within 7 days. It is important to keep in mind that both state and federal laws must be complied with.
Step-by-Step Workflow for California Pharmacies
1) Verify Caller Authority and Prescriber Identity
Confirm caller name and role.
Confirm prescriber name and contact information.
Use a callback verification protocol if the prescriber is unknown. Federal law contemplates reasonable efforts to verify identity when needed.
2) Confirm Hospice Context
Identify the hospice provider.
Confirm hospice status through chart documentation, hospice contact, or patient profile. If using a hospice-specific pathway, ensure you will receive necessary documentation.
3) Capture Full Prescription Details
Document:
Drug, strength, dosage form
Directions, quantity, refills
Date/time of call
Caller + pharmacist identifiers
Oral prescriptions must be reduced to a record promptly.
4) Choose the Correct Schedule II Pathway
Preferred order of operations:
eRx (always preferred)
Emergency oral Schedule II (only if truly qualifies)
5) Report to CURES On Time
California requires reporting controlled substance dispensing to CURES generally no later than one working day after release.
6) Follow-Up Documentation
A daily cadence should be established with prescribers to ensure a prescription is received within 7 days.
The pharmacist in charge should report any failure to obtain a prescription after the 7 days to the DEA.
Common Pitfalls (What Not to Do)
Don’t treat “hospice” as a blanket exception for Schedule II phone orders.
Don’t use emergency oral Schedule II unless you can meet all conditions.
Don’t dispense beyond the emergency quantity.
Don’t skip identity verification if the prescriber is unknown.
Don’t operate without a 7-day tracking process if you ever use emergency oral Schedule II.
If the Follow-Up Prescription Isn’t Received Within 7 Days
This section applies specifically to emergency oral Schedule II prescriptions.
Federal law requires the prescriber to provide a written prescription within 7 days marked “Authorization for Emergency Dispensing,” including the date of the oral order.
What the Pharmacy Must Do on Day 7 (If Nothing Arrives)
1) Stop further dispensing tied to that emergency oral authorization.
2) Document your outreach efforts.
Record:
Dates/times of calls
Who you spoke to
What was requested
Outcomes
3) Notify the DEA if the prescriber fails to provide the required follow-up prescription. The pharmacist or PIC must notify the nearest DEA office.
Conclusion: Ensuring Compliance and Patient Safety
Navigating the complexities of hospice care and controlled substance regulations is critical for pharmacies. By following the outlined steps and maintaining a robust compliance framework, we can ensure that we meet both state and federal requirements. This not only protects our licenses but also enhances patient safety and care quality.
For more information about compliance and best practices, visit Pharmasys Solutions LLC.
Regulatory Sources:
California Business & Professions Code §4070
California Health & Safety Code §11167.5
21 CFR §1306.11
CA B&P §4070
CA H&S §11164
21 CFR §1306.11
Comments